COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC - News) today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to ...

The Spectranetics Corp. said it received clearance of its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Colorado Springs, Colorado-based company ...

COLORADO SPRINGS, Colo., Jul 01, 2010 (BUSINESS WIRE) -- Spectranetics Corporation /quotes/comstock/15*!spnc/quotes/nls/spnc (SPNC 5.19, +0.03, +0.58%) today ...

The U.S. FDA’s final guidance for clinical decision support (CDS) systems may be the subject of two citizen’s petitions requesting the agency scrap the guidance ...

ORLANDO, Florida — Transvenous extraction of unused pacemaker or defibrillator leads poses a higher risk for death as an acute complication when it's performed by using a laser-based extraction sheath ...